Artificial Intelligence for Brain Network Plasticity Modeling

Abstract

Artificial intelligence (AI) has rapidly emerged as a transformative force in neuroscience, particularly in the study and modeling of brain network plasticity. By leveraging advanced machine learning algorithms and deep learning architectures, AI enables the integration of multi-modal neuroimaging and neurophysiological data to map, predict, and even manipulate the dynamic reorganization of neural circuits. This review synthesizes current evidence on the application of AI in brain network plasticity modeling, explores its clinical relevance, and discusses future directions for research and clinical translation, with a focus on implications for neurological disease management and rehabilitation.

Introduction

Brain network plasticity refers to the ability of neural circuits to adapt structurally and functionally in response to intrinsic and extrinsic stimuli, underpinning learning, memory, recovery from injury, and the progression of various neurological disorders. Traditional research approaches have provided critical insights, but the increasing complexity and volume of neurobiological data now demand more sophisticated analytical methods. AI, with its capacity for pattern recognition and predictive modeling, offers unique opportunities to deepen our mechanistic understanding and clinical application of brain plasticity. This article reviews the epidemiology, mechanisms, clinical features, diagnosis, treatment, recent advances, and guideline recommendations on the use of AI in brain network plasticity modeling, targeting healthcare professionals seeking up-to-date, evidence-based information.

Epidemiology / Disease Burden

Disruptions in brain network plasticity are implicated in a wide range of neurological and psychiatric conditions, including stroke, traumatic brain injury, epilepsy, neurodegenerative disorders (such as Alzheimer's and Parkinson's disease), schizophrenia, and depression. Globally, stroke alone accounts for over 12 million new cases annually, with significant morbidity attributable to impaired neural reorganization. The societal and economic burden of brain plasticity-related dysfunctions is compounded by aging populations and increased survival from acute neurological insults. Accurate modeling of brain network plasticity is thus critical not only for advancing neuroscience research but also for informing rehabilitation strategies, predicting recovery trajectories, and personalizing interventions.

Pathophysiology

At the cellular level, brain plasticity encompasses synaptic potentiation and depression, neurogenesis, axonal sprouting, and dendritic remodeling. These processes are modulated by molecular signaling cascades, glial cell interactions, and the extracellular matrix. At a systems level, plasticity manifests as changes in functional and structural connectivity, measurable via techniques such as fMRI, DTI, and EEG. AI models, particularly those based on graph theory and connectomics, can capture these complex, large-scale network dynamics. For example, supervised learning algorithms can identify non-linear relationships between regional brain activity and functional outcomes, while unsupervised models reveal latent connectivity patterns associated with specific disease states or interventions.

Risk Factors

Many factors influence brain network plasticity, including age, sex, genetic predisposition, environmental enrichment, and pre-existing comorbidities. Neurological insults such as ischemia, trauma, or inflammation can either promote adaptive plasticity or precipitate maladaptive network reorganization. AI-driven analyses can stratify patients by risk profiles, integrating clinical, demographic, and biomarker data to forecast individual trajectories of plasticity and recovery. Moreover, machine learning models can be trained to recognize subtle risk patterns that may escape traditional statistical methods, supporting early intervention and tailored rehabilitation strategies.

Clinical Features

The clinical manifestations of altered brain network plasticity are diverse and context-dependent. In stroke, for example, impaired plasticity is associated with persistent motor, sensory, or cognitive deficits. In epilepsy, aberrant network reorganization can contribute to seizure propagation. Neurodegenerative diseases often feature progressive loss of functional connectivity correlating with cognitive and behavioral decline. AI-enabled modeling provides a framework for linking specific network changes to clinical phenotypes, enhancing diagnostic precision and monitoring of disease progression or therapeutic response.

Diagnosis

Diagnosis of plasticity-related dysfunctions has traditionally relied on neuroimaging, neuropsychological testing, and clinical assessment. AI enhances these modalities by automating image segmentation, feature extraction, and pattern classification. Deep learning architectures, such as convolutional neural networks (CNNs), can process complex imaging datasets to detect subtle changes indicative of plasticity. Additionally, recurrent neural networks (RNNs) can analyze temporal sequences of neurophysiological data, facilitating real-time monitoring of network reorganization during interventions such as neurorehabilitation or neuromodulation.

Treatment & Management

Effective management of conditions involving brain network plasticity often requires a multidisciplinary approach, including pharmacological therapy, neurorehabilitation, cognitive training, and neuromodulation (e.g., transcranial magnetic stimulation). AI models can predict patient-specific responses to these interventions by integrating multimodal data, thus guiding personalized treatment planning. Furthermore, AI-driven digital therapeutics and adaptive neurofeedback platforms are emerging, allowing dynamic adjustment of interventions based on real-time monitoring of brain activity and plasticity markers.

Recent Advances / Emerging Therapies

Recent advances in AI for brain network plasticity modeling include the development of explainable AI (XAI) frameworks, which improve model transparency and clinician trust. Generative models, such as variational autoencoders and generative adversarial networks (GANs), are being used to simulate hypothetical network changes and predict outcomes following interventions. Integrative omics approaches, combining genetics, proteomics, and connectomics, are now feasible through AI, offering new insights into the molecular underpinnings of plasticity. Additionally, reinforcement learning is being applied to optimize neurorehabilitation protocols, enabling adaptive, goal-oriented therapy that maximizes functional recovery.

Guideline Recommendations

Consensus guidelines from leading neurological and neurorehabilitation societies increasingly recognize the role of AI in advancing brain network plasticity research and clinical practice. Recommendations emphasize the need for robust validation of AI models, interdisciplinary collaboration, and ethical considerations surrounding data privacy and algorithmic bias. Clinicians are encouraged to integrate AI-driven tools as adjuncts to, rather than replacements for, expert clinical judgment. Ongoing education and training are essential to ensure appropriate interpretation and application of AI-derived insights in patient care.

Conclusion

The application of artificial intelligence to brain network plasticity modeling represents a paradigm shift in neuroscience and clinical practice. By enabling high-dimensional data integration, predictive analytics, and individualized therapy planning, AI holds the promise of improving outcomes for patients with neurological and psychiatric conditions. Realizing this potential will require continued research, validation, and multidisciplinary engagement to ensure that AI technologies are deployed safely, ethically, and effectively in real-world clinical settings.